Figure 3.

All-cause mortality following treatment with cisplatin and etoposide for clinical trial patients and elderly usual care medicare patients with extensive stage small cell lung cancer. A two-sided log-rank test was used to compare the survival distributions of patients according to group membership. CMS = Centers for Medicare and Medicaid Services.